Ignite Creation Date:
2025-12-24 @ 7:16 PM
Ignite Modification Date:
2026-01-01 @ 12:10 AM
Study NCT ID:
NCT04794803
Status:
TERMINATED
Last Update Posted:
2024-01-08
First Post:
2021-03-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Reparixin in COVID-19 Pneumonia - Efficacy and Safety
Sponsor:
Dompé Farmaceutici S.p.A
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
REPAVID-19
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None